- Home
- JFR vs ATRC Comparison
JFR vs ATRC Comparison
Compare JFR & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFR
- ATRC
- Stock Information
- Founded
- JFR 2004
- ATRC 2000
- Country
- JFR United States
- ATRC United States
- Employees
- JFR N/A
- ATRC N/A
- Industry
- JFR Trusts Except Educational Religious and Charitable
- ATRC Medical/Dental Instruments
- Sector
- JFR Finance
- ATRC Health Care
- Exchange
- JFR Nasdaq
- ATRC Nasdaq
- Market Cap
- JFR 1.1B
- ATRC 1.6B
- IPO Year
- JFR N/A
- ATRC 2005
- Fundamental
- Price
- JFR $8.51
- ATRC $31.76
- Analyst Decision
- JFR
- ATRC Strong Buy
- Analyst Count
- JFR 0
- ATRC 10
- Target Price
- JFR N/A
- ATRC $49.60
- AVG Volume (30 Days)
- JFR 621.7K
- ATRC 424.4K
- Earning Date
- JFR 01-01-0001
- ATRC 07-29-2025
- Dividend Yield
- JFR 11.31%
- ATRC N/A
- EPS Growth
- JFR N/A
- ATRC N/A
- EPS
- JFR N/A
- ATRC N/A
- Revenue
- JFR N/A
- ATRC $480,076,000.00
- Revenue This Year
- JFR N/A
- ATRC $14.63
- Revenue Next Year
- JFR N/A
- ATRC $12.62
- P/E Ratio
- JFR N/A
- ATRC N/A
- Revenue Growth
- JFR N/A
- ATRC 15.79
- 52 Week Low
- JFR $7.61
- ATRC $20.20
- 52 Week High
- JFR $8.82
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- JFR 72.96
- ATRC 44.34
- Support Level
- JFR $8.35
- ATRC $30.85
- Resistance Level
- JFR $8.29
- ATRC $33.15
- Average True Range (ATR)
- JFR 0.05
- ATRC 0.98
- MACD
- JFR 0.02
- ATRC -0.10
- Stochastic Oscillator
- JFR 100.00
- ATRC 36.52
About JFR Nuveen Floating Rate Income Fund
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income, consistent with the preservation of capital. It invests in adjustable-rate U.S. dollar-denominated secured Senior Loans.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.